✦ LIBER ✦

PDB8 THE IMPACT OF IMPROVED BETA-CELL FUNCTION ON MODELLING THE COST-EFFECTIVENESS OF ROSIGLITAZONE IN THE MANAGEMENT OF TYPE 2 DIABETES IN SPAIN

✍ Scribed by A Shearer; A Bagust; FJ Ampudia-Blasco; MJ TaylorJ; S Mendes da Costa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB26 COST-EFFECTIVENESS OF ROSIGLITAZON

✍ T Doležal; J Skoupá; MJ Taylor; S Whitehead; V Rausova; P Pavlikova 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Spotlight on Rosiglitazone in the Manage

✍ Antona J. Wagstaff, Karen L. Goa 📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 85 KB

Interventions to Preserve Beta-Cell Func

✍ Kathleen A. Page, Tamar Reisman 📂 Article 📅 2013 🏛 Current Science Inc. 🌐 English ⚖ 225 KB

The burden of type 2 diabetes in Serbia

✍ Vesna Bjegovic; Zorica Terzic; Jelena Marinkovic; Nebojsa Lalic; Sandra Sipetic; 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 140 KB

Cost-effectiveness of liraglutide versus

✍ Lee, W.C.; Conner, C.; Hammer, M. 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 311 KB